SP1 and Miyoshi myopathy: Furthermore, because a growing body of evidence indicates a critical role of Sp1 in tumor initiation and/or maintenance of self-renewal capacity in various types of cancers [5], Sp1 inhibition with these strategies may impair MM initiating cells or progenitors together with MM cells with a mature phenotype.